International Journal of Clinical Oncology
Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population
Catheter-related bloodstream infection with removal of catheter in pediatric oncology patients: a 10-year experience in Taiwan
Clinical evidence of particle beam therapy
Clinical evidence of particle beam therapy (carbon)
Clinical evidence of particle beam therapy (proton)
Clinical significance of Rho GDP dissociation inhibitor 2 in colorectal carcinoma
Duodenal metastasis from recurrent invasive lobular carcinoma of breast: a case report and literature review
Extrapancreatic solid pseudopapillary tumor: case report and review of the literature
High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers
Identification of serum biomarkers for ovarian cancer using MALDI–TOF-MS combined with magnetic beads
Perceptions and attitudes of Japanese gynecologic cancer patients to Kampo (Japanese herbal) medicines
Phase I study of irinotecan by 24-h intravenous infusion in combination with 5-fluorouracil in metastatic colorectal cancer
Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer
Radiotherapy for mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus: a case report with a diagnostic and therapeutic discussion
Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303
Sinonasal-type hemangiopericytoma of the nasal cavity and paranasal sinus
Successful treatment of primary malignant lymphoma of the penis by organ-preserving rituximab-containing chemotherapy
Synchronous and metachronous ureteric metastases from adenocarcinoma of the colon
The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer
Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib